HomeCompareSDMHF vs NOBL

SDMHF vs NOBL: Dividend Comparison 2026

SDMHF yields 0.39% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SDMHF wins by $328.5K in total portfolio value· pulled ahead in Year 4
10 years
SDMHF
SDMHF
● Live price
0.39%
Share price
$193.00
Annual div
$0.75
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$351.4K
Annual income
$234,602.49
Full SDMHF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — SDMHF vs NOBL

📍 SDMHF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSDMHFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SDMHF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SDMHF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SDMHF
Annual income on $10K today (after 15% tax)
$32.81/yr
After 10yr DRIP, annual income (after tax)
$199,412.12/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, SDMHF beats the other by $199,202.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SDMHF + NOBL for your $10,000?

SDMHF: 50%NOBL: 50%
100% NOBL50/50100% SDMHF
Portfolio after 10yr
$187.1K
Annual income
$117,424.34/yr
Blended yield
62.76%
📊

Analyst Conviction Gap

Where Wall Street is split right now

SDMHF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
3.9
Piotroski
7/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SDMHF buys
0
NOBL buys
0
No recent congressional trades found for SDMHF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSDMHFNOBL
Forward yield0.39%2.14%
Annual dividend / share$0.75$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$351.4K$22.8K
Annual income after 10y$234,602.49$246.19
Total dividends collected$321.4K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SDMHF vs NOBL ($10,000, DRIP)

YearSDMHF PortfolioSDMHF Income/yrNOBL PortfolioNOBL Income/yrGap
1$10,777$77.20$10,914$214.34$137.00NOBL
2$11,687$155.52$11,897$218.63$210.00NOBL
3$12,820$315.23$12,952$222.72$132.00NOBL
4← crossover$14,364$646.35$14,086$226.62+$278.00SDMHF
5$16,723$1,353.62$15,302$230.33+$1.4KSDMHF
6$20,840$2,945.67$16,607$233.85+$4.2KSDMHF
7$29,160$6,861.15$18,007$237.18+$11.2KSDMHF
8$49,145$17,944.60$19,508$240.35+$29.6KSDMHF
9$109,116$56,530.29$21,116$243.35+$88.0KSDMHF
10$351,356$234,602.49$22,841$246.19+$328.5KSDMHF

SDMHF vs NOBL: Complete Analysis 2026

SDMHFStock

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Full SDMHF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this SDMHF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SDMHF vs SCHDSDMHF vs JEPISDMHF vs OSDMHF vs KOSDMHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.